Drug Profile
MDI-P
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Medical Discoveries
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Cystic fibrosis; HIV infections; Mycoses; Sepsis; Viral infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in HIV-infections in Cayman Islands
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in HIV-infections in Mexico
- 04 Nov 2017 No recent reports of development identified for preclinical development in Asthma in USA